Discovery of a novel DDRs kinase inhibitor XBLJ-13 for the treatment of idiopathic pulmonary fibrosis

Ying Dong(University of Chinese Academy of Sciences), Yi Zang(National Center for Drug Screening)

Acta Pharmacologica Sinica

November 24, 2021

10.1038/s41401-021-00808-z

Cited by 15

Related Papers

Leukemia incidence trends at the global, regional, and national level between 1990 and 2017

|Experimental Hematology and Oncology|2020|346

Phosphorylation of PHF2 by AMPK releases the repressive H3K9me2 and inhibits cancer metastasis

|Signal Transduction and Targeted Therapy|2023|111

Roxithromycin attenuates bleomycin-induced pulmonary fibrosis by targeting senescent cells

|Acta Pharmacologica Sinica|2021|54

AMP-activated Protein Kinase Is Involved in Neural Stem Cell Growth Suppression and Cell Cycle Arrest by 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside and Glucose Deprivation by Down-regulating Phospho-retinoblastoma Protein and Cyclin D

|Journal of Biological Chemistry|2009|50